Latest News & Features
Refine Search
Americas
IP litigator Thomas Wintner has been appointed partner at Edwards Wildman Palmer LLP. 6 January 2014
Americas
Biopharmaceutical company AstraZeneca has paid $4.1 billion to acquire Bristol Myers Squibb’s share of the firms’ diabetes business venture. 20 December 2013
Americas
The US District Court for the District of Delaware has upheld the validity of a GSK-held patent that covers two HIV drugs marketed in the US by ViiV Healthcare. 19 December 2013
Americas
Viagra-maker Pfizer Ltd and Teva Pharmaceutical Industries have agreed to settle patent litigation related to Teva’s generic version of Viagra (sildenafil citrate) tablets. 19 December 2013
Americas
Mylan Pharmaceuticals and its partner Banner Pharmacaps Inc, a subsidiary of Patheon Inc, have entered into a settlement and licence agreement with Japanese pharmaceutical company Eisai Inc and Valeant Pharmaceuticals Luxembourg S.a.r.l. 18 December 2013
article
AstraZeneca has sued Aurobindo Pharma Limited and its US-based subsidiary Aurobindo Pharma USA Inc for infringing four of its patents related to heartburn drug Nexium. 17 December 2013
Big Pharma
European Patent Office president Benoît Battistelli has praised the “steady” progress that the Unitary Patent and its associated court have made this year. 17 December 2013
Americas
The US Food and Drug Administration (FDA) has approved the first generic versions of antidepressant drug Cymbalta (duloxetine hydrochloride), after Eli Lilly’s primary patent covering the product expired on December 11. 16 December 2013
Americas
Canadian law firm Davis LLP has strengthened its life sciences department with the addition of Sara Zborovski as partner. 13 December 2013
Asia-Pacific
The High Court in Australia has said for the first time that a method of medical treatment for the human body can be a patentable invention. 12 December 2013